LACunar Intervention (LACI-2) Trial: Assessment of safety and efficacy of cilostazol and isosorbide mononitrate to prevent recurrent lacunar stroke and progression of cerebral small vessel disease.

Project Details

StatusFinished
Effective start/end date1/03/18 → 31/12/22

Funding

  • UK-based charities: £423,198.00